German pharma manufacturer Boehringer Ingelheim is planning to increase its investments in Egypt by 15-20% in 2018, Al Mal reports. The company invests around EGP 20 mn in Egypt each year and is eyeing new investments during the coming period in light of improving business conditions,Marketing Director Mohamed Dababy tells the newspaper.
More from Enterprise
How correspondent banking works, and what the FinCEN clampdown on Banque Misr UAE means for business
As FinCEN proposes cutting Banque Misr’s UAE branches from USD…
Banks threaten to look beyond London as windfall tax talk grows
International lenders say more tax could tip the balance as…
EFG has three more IPOs lined up before year-end, including one hefty offering
Group CEO Karim Awad credits the central bank’s decision to…
Egyptian-UK fintech Zeal raises USD 10 mn to back expansion plans
The London-based, Egyptian-founded fintech is preparing to activate its loyalty…